Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
SAMSARA BIOCAPITAL, L.P.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
2017
Entity Type
LIMITED PARTNERSHIP
Item 2 Issuer Principal Place of Business and Contact Information
565 EVERETT AVENUE
PALO ALTO, CA 94301
Phone Number:
subscription required
Item 3. Related Persons
Name
N/A N/A SAMSARA BIOCAPITAL GP, LLC
Address
subscription required
Relationship(s)
Clarification of Response
GENERAL PARTNER OF THE ISSUER (THE GENERAL PARTNER)
Item 3. Related Persons
Name
SRINIVAS AKKARAJU
Address
subscription required
Relationship(s)
Clarification of Response
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
Item 3. Related Persons
Name
MICHAEL DYBBS
Address
subscription required
Relationship(s)
Clarification of Response
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
Item 4. Industry Group
POOLED INVESTMENT FUND
- VENTURE CAPITAL FUND
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
First Sale Yet to Occur
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Pooled Investment Fund Interests
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
300000000
Total Amount Sold
0
Total Remaining to be Sold
300000000
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
0
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
THE GENERAL PARTNER (OR AN AFFILIATE THEREOF) IS ENTITLED TO A MANAGEMENT FEE.
Signature and Submission
Issuer Name
SAMSARA BIOCAPITAL, L.P.
Issuer Signature
/S/ SRINIVAS AKKARAJU
Signer Name
SRINIVAS AKKARAJU
Signer Title
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
Signature Date
03/21/2017